TAAT ™ Expands Northeastern US Footprint with Additional 350

LAS VEGAS and VANCOUVER, British Columbia, December 03, 2021 (GLOBE NEWSWIRE) – TAATâ„¢ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to announce that TAAT â„¢ Original, Smooth, and Menthol will be sold in 350 retail stores in the state of Virginia (population 8.5 million1, with a smoking rate of 14% among adults2) in addition to its existing stores in Richmond, Virginia. This placement was achieved through the Company’s relationship with a national distributor of convenience stores, which guaranteed countertop placement of TAAT â„¢ displays near point-of-sale stations in each store. After initially launching TAAT â„¢ in Ohio in December 2020, the company added stores in other parts of the United States, including near Ohio markets in the northeast region of the country, such as Michigan, West Virginia and Pennsylvania, where the established presence of TAAT â„¢ appears to be a catalyst for growth.

In about a year, TAAT ™ expanded its footprint from a single “test market” area in northern Ohio to a national presence in more than two dozen states, as well as US territories to include Puerto Rico and Guam. The company has leveraged existing demand for TAAT ™ from smokers aged 21 and over by proactively building relationships with wholesalers that serve mainstream tobacco retailers such as liquor stores and convenience stores. As TAAT ™ distributors continue to receive repeat orders from their accounts, the Company has undertaken strategic regional efforts to capitalize on the growing momentum. With the addition of these 350 new stores in Virginia, the Company seeks to further expand its retail base on the east coast of the United States, complementing its existing strong presence in the state of Georgia.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6be1b6fc-57de-4779-9ba6-53871210ae4d

The company shipped 350 pre-filled TAAT ™ displays containing the three varieties “Original”, “Smooth” and “Menthol” for placement in 350 new retail outlets in the US state of Virginia, where TAAT ™ already has. a presence in the city of Richmond

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

TAAT ™ CEO Setti Coscarella said: “Now that we have had the opportunity to benefit from the insights made during our TAAT ™ launches in several markets in the United States, we have succeeded in reducing our coordination times. and execution launches with new distributors. TAAT ™ has been sold in Ohio for almost a year, which has allowed us to passively build our footprint in neighboring states through organic growth. Although TAAT ™ is already sold in Virginia, one of our national wholesale partners was able to line up an additional 350 retailers, with whom we are also assured of “top notch” placement on the counters of TAAT displays. ™ in all stores; a tactic that has already proven to be effective enough to capture the attention of smokers 21 and over at the point of sale. We look forward to seeing how TAAT ™ performs in these new stores, representing our latest launch in the Northeastern United States.


1 – https://www.census.gov/quickfacts/VA

2 – https://www.cdc.gov/statesystem/cigaretteuseadult.html

On behalf of the Board of Directors of the Company,


“Setti Coscarella”

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT â„¢ Investor Relations
1-833-TAAT-United States (1-833-822-8872)
[email protected]


About TAATâ„¢ Global Alternatives Inc.

The Company has developed TAAT â„¢, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in the “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT â„¢ is Beyond Tobacco â„¢, a proprietary blend that undergoes a patent pending refinement technique that makes its scent and taste resemble tobacco. Under the leadership of management with the “Big Tobacco” pedigree, TAAT â„¢ was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself in the $ 814 billion mark.1 the global tobacco industry.

For more information, please visit http://taatglobal.com.

The references

1 British American Tobacco – The Global Market

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “believes” , “Intention”, “” anticipates “or” does not anticipate “, or” believes “, or variations of these words and expressions or declares that certain actions, events or results” could “,” could “,” would “,” could “or” be “to be taken, to occur or to be achieved. Forward-looking information contained in this press release includes statements regarding the anticipated performance of TAAT â„¢ in the tobacco industry, in addition to the following : Arrival of delivery of TAAT â„¢ to 350 new stores in Virginia Forward-looking information reflects management’s current expectations based on information currently available and is subject to a number of risks and uncertainties that may result in that the re Results differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, such information should not be relied on unduly and no assurance can be given that such events will occur within the time limits disclosed or in the future. all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , unless required by applicable law.

The statements contained in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. Because everyone is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or guarantee can be made as to the effects of the Company’s products on the health and well-being of an individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third party entities (or their respective offerings with brand names) generally in reference to (i) the relationship between the Company and third party entities mentioned in this release and / or (ii ) the client / supplier / service provider parties whose relationship with the Company is / are mentioned in this press release. All rights to these trademarks are reserved by their respective owners or licensees.

Statement Regarding Third Party Investor Relations Firms

Information relating to investor relations companies retained by TAAT â„¢ Global Alternatives Inc. can be viewed under the company profile at http://sedar.com.

About Margaret Shaw

Check Also

Top FDA tobacco official resigns to take job at Philip Morris International

OOn July 26, Matthew Holman, director of the Food and Drug Administration’s Center for Tobacco …